<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00488124</url>
  </required_header>
  <id_info>
    <org_study_id>NRA6280030</org_study_id>
    <nct_id>NCT00488124</nct_id>
  </id_info>
  <brief_title>Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin</brief_title>
  <acronym>ISS</acronym>
  <official_title>Evaluation of Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin: A Prospective, Longitudinal Non-randomised, Open, Phase II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Growth hormone therapy will improve the height of short statured children with pathological
      conditions that lead to growth retardation. Growth hormone therapy will show an increase in
      height velocity &gt;1 SD compared to pretreatment height velocity. and the therapy will be safe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Growth hormone (GH, Somatropin, e.g. Genotropin®) is approved in the treatment of children in
      specific indications. However, besides the benefit in approved indications, a benefit can
      also be achieved in other pathological conditions that lead to growth retardation. However,
      because of their relative low frequency and the long duration of GH studies in children, few
      data or only case reports on GH treatment are available in these conditions. Nevertheless,
      published data have suggested a benefit of GH treatment in children suffering from some of
      those diseases and pediatric endocrinologists sometimes request GH treatment for those
      children to improve growth rate. This protocol is designed to allow such children with severe
      growth retardation to be treated with GH and will allow those children to be carefully
      followed-up and finally evaluated at the end of the GH treatment period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To show an improvement of height, change in height (SDS) under GH treatment one year after visit 2 (start of GH therapy).</measure>
    <time_frame>one and two years of observation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To show an increase in height velocity &gt;1 SD compared to pretreatment height velocity, to confirm good clinical and biological safety of GH treatment in these patients (e.g. adverse events, serum IGF-I, fasting blood glucose and insulin)</measure>
    <time_frame>one and two years of observation period</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Idiopathic Short Stature</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>somatropin (Genotropin® treatment)</intervention_name>
    <description>0,035 mg /kg bodyweight of Somatropin per day given by subcutaneous injections through an injection device (GenotropinPEN)</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe growth retardation (&lt; -2,5 height SDS and annual growth velocity (HV SDS) &lt; 0
             SD according to Reinken (1992) and parental adjusted target height &lt; -1 SD according
             to Tanner (1986)

          -  Chronological age &gt; 4 and &lt; 10 years, prepubertal children; for girls: Tanner breast
             stage B = 1, for boys: testis volume ≤ 3 ml

          -  Any disease which is NOT part of the registered indications for GH treatment in
             Germany

          -  Written informed consent from both parents and from the patients if she/he is able to
             receive and understand the information

          -  GH treatment requested by an expert in pediatric endocrinology

        Exclusion Criteria:

          -  Participation in any other clinical study

          -  Unable to follow the and/or comprehend the protocol ( e.g. severe mental retardation)

          -  Previous history of intolerance or hypersensitivity to the study drug

          -  History of malignancy

          -  Chromosomal anomalies with increased risk for malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmuth-Günther Doerr, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Friedrich-Alexander-Universität Erlangen-Nürnberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kinderklinik, Universitätsklinikum der RWTH Aachen, Pauwelsstraße 30</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Kinder und Jugendliche der Technischen Universität Dresden, Fetscherstr. 74</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Kinder und Jugendliche, Schwerpunkt Kinder-Endokrinologie und - Diabetologie, Loschgestr. 15</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Päd. Hämatologie, Onkologie und Endokrinologie, Zentrum für Kinderheilkunde, der Universität Duisburg-Essen, Hufelandstrasse 55</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinder- und Jugendärztin, Pippinplatz 4</name>
      <address>
        <city>Gauting</city>
        <zip>82131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endokrinologikum Hamburg, Lornsenstrasse 4 - 6</name>
      <address>
        <city>Hamburg</city>
        <zip>22767</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderarztpraxis, Brabeckstrasse 153</name>
      <address>
        <city>Hannover</city>
        <zip>30539</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendliche, Abt. Kinderheilkunde, Im Neuenheimer Feld 430</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendmedizin, Kirrberger Strasse</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik u. Poliklinik für Kinder und Jugendliche, Med. Einrichtungen der Universität Köln, Joseph-Stelzmann-Strasse 9</name>
      <address>
        <city>Köln</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum für Frauen und Kindermedizin, Liebigstrasse 20 a</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Allgemeine Pädiatrie und Neonatologie, Otto-von-Guericke-Universität Magdeburg, Leipziger Straße 44</name>
      <address>
        <city>Magdeburg</city>
        <zip>39112</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Kinderheilkunde und Jugendmedizin, Sektion Pädiatrische Endokrinologie, Hoppe-Seyler-Straße 1</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2007</study_first_submitted>
  <study_first_submitted_qc>June 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2007</study_first_posted>
  <last_update_submitted>March 29, 2011</last_update_submitted>
  <last_update_submitted_qc>March 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2011</last_update_posted>
  <responsible_party>
    <name_title>Professor Dr. med. Doerr</name_title>
    <organization>Childrens´ hospital</organization>
  </responsible_party>
  <keyword>short stature</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

